Tag: Prescription Drugs
Biomarkers Elevated in Patients With Immune Checkpoint Inhibitor-Induced Myocarditis
Elevations in creatine phosphokinase had sensitivity and specificity of 99 and 23 percent, respectively, for identifying myocarditis
DAAs Less Likely for Hep C Patients With Alcohol Use Disorder
Those with current alcohol use disorder or abstinent with alcohol use disorder history had lower likelihood of receiving direct-acting antivirals
Drug Approved to Help Young Patients Battle a Rare Cancer
Trial funded by the NCI has prompted the FDA to approve Tecentriq for children and adults with alveolar soft part sarcoma
Adverse Events Increased for Induced Abortion With Mifepristone-Misoprostol
Serious adverse events are rare, occur more often with mifepristone-misoprostol versus procedural induced abortion in first trimester
ACP Updates Living Guideline on Pharmacologic Treatment of Osteoporosis
Bisphosphonates strongly recommended for initial treatment of primary osteoporosis for postmenopausal women
Occurrence of Cardiovascular Events, Death Compared Between Thiazides
Occurrence of major cardiovascular events, non-cancer-related deaths no lower with chlorthalidone versus hydrochlorothiazide
Progression-Free Survival Increased With Zanubrutinib in Leukemia
Longer progression-free survival seen with zanubrutinib versus ibrutinib for patients with relapsed or refractory chronic or small lymphocytic leukemia
Congressional Report Slams FDA, Drugmaker Over Approval of Alzheimer Drug Aduhelm
Controversy over Aduhelm stretches back to its June 2021 approval by the U.S. Food and Drug Administration
Molnupiravir Does Not Reduce COVID-19-Related Hospitalization, Death
No reduction in COVID-19-associated hospitalizations or deaths seen among high-risk, vaccinated adults
5α-Reductase Inhibitors Linked to Depression, but Not Dementia
Magnitude of association for finasteride and dutasteride with dementia decreased over time and became nonsignificant
